INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

20,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

Page 344 of 524
← PrevNext →
1
PA
Pena Fernando AustinDirector, President
BXMTBLACKSTONE MORTGAGE TRUST, INC.
Open-market sale · 10b5-1 plan
SELL
$31K
1,666 sh
Mar 31, 2026
Apr 1, 2026
traded Mar 31, 2026
+1d
SEC Form 4

Evidence

50
WS
Weaver Robert S.EVP, Government Relations
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$399K
1,872 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

50
MR
Morgan RachelEVP General Counsel
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$668K
3,127 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

47
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$434K
2,161 sh
Mar 6, 2026Mar 31, 2026
traded Mar 6, 2026
+25dSEC Form 4

Evidence

44
DD
Degner DennisChief Executive Officer & Pres
RRCRANGE RESOURCES CORP
Open-market sale
SELL$693K
15.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

40
Mark AlfordRSelf
AMZNAMAZON COM INC
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

40
PM
Preston Tracy MEVP, CLO & Corporate Secretary
MMacy's, Inc.
Open-market sale
SELL$49K
2,736 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

39
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Open-market sale
SELL$54K
3,051 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

39
WG
Weitman GarySee Remarks
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$214K
1,005 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

36
MW
McDowell Erin WSVP & General Counsel
RRCRANGE RESOURCES CORP
Open-market sale
SELL$396K
8,250 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

35
SS
Szabo ShandellDirector
MGYMagnolia Oil & Gas Corp
Open-market sale
SELL$375K
11.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

35
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$69K
1,252 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

33
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$128K
4,256 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

33
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$146K
4,864 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

32
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$17K
313 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

32
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,991
74 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

30
GD
Garagic DenisCHIEF TECHNOLOGY OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$84K
15.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

29
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$65K
2,100 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

29
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$57K
1,838 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

29
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

27
TT
Thatcher TrevorCHIEF FINANCIAL OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$17K
3,030 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

27
SS
Sonne StephenCHIEF LEGAL OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$19K
3,471 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

26
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$18K
558 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

26
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$15K
488 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

26
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale · 10b5-1 plan
SELL$268K
50.0K sh
Mar 26, 2026Mar 31, 2026
traded Mar 26, 2026
+5dSEC Form 4

Evidence

25
Mark AlfordRSelf
BRK.Bsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share Berkshire Hathaway Inc. New Common Stock
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

25
Mark AlfordRSelf
AAPLApple Inc.
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

25
TM
Tirman MatthewPresident
SATLSatellogic Inc.
Open-market sale
SELL$49K
9,499 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

24
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$332K
68.0K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

21
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$3,000
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

20
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale · 10b5-1 plan
SELL$265K
50.0K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

20
Mark AlfordRSelf
SDsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share DIA - State Street SPDR Dow Jones Indust Avg ETF Trust NYSEARCA: DIA
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

20
Mark AlfordRSelf
TAT&T INC.
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

20
Mark AlfordRSelf
SPYBsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share SPDR S&P 500 Buyback ETF
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

20
Mark AlfordRSelf
SQsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share Invesco QQQ
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

20
Mark AlfordRSelf
SPYBsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share SPDR S&P 500 Buyback ETF
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

20
Mark AlfordRSelf
PYPLPayPal Holdings, Inc.
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$241K
19.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$220K
16.3K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence